Prescription drug · ANDA
BUPIVACAINE HCl (Bupivacaine hydrochloride) NDC 70594-115
Bupivacaine hydrochloride 2.5 mg/mL · Injection, Solution · Epidural, Intracaudal, Perineural · Xellia Pharmaceuticals USA LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70594-115-01 | 7059401150170594011501 | 30 mL in 1 VIAL, SINGLE-DOSE (70594-115-01)Marketed from Jun 1, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- BUPIVACAINE HCl
- Generic name (nonproprietary)
- bupivacaine hydrochloride
- Active ingredients
- Bupivacaine hydrochloride — 2.5 mg/mL
- Dosage form
- Injection, Solution
- Route
- Epidural, Intracaudal, Perineural
- Labeler
- Xellia Pharmaceuticals USA LLCNDC labeler code 70594
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 091487
- Marketing start
- Listing expires
- Other FDA classes
- Amides (Chemical structure)Local Anesthesia (Physiologic effect)
- Identifiers
- Product ID 70594-115_afc179ac-71b9-4021-8b71-3372bf590e4aSPL ID afc179ac-71b9-4021-8b71-3372bf590e4aSPL set ID f29c905e-9a55-446f-a89d-860ad9ade7adRxCUI 1724786, 1724787, 1724880, 1724884, 1725078, 1725082UNII 7TQO7W3VT8
- Pharmacologic class
- Amide Local Anesthetic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N470594011501followed by a unit qualifier and the quantityPackage 70594-0115-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Bupivacaine hydrochloride injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations of bupivacaine hydrochloride injection are recommended for each type of block indicated to produce local or regional anesthesia or analgesia [see Dosage and Administration (2.2) ]. Bupivacaine hydrochloride injection contains bupivacaine, an amide local anesthetic. Bupivacaine hydrochloride injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery and oral surgery proce…
Excerpt only. Read the full label for complete information.
About NDC 70594-115
- What is NDC 70594-115?
- 70594-115 is the product NDC for BUPIVACAINE HCl (bupivacaine hydrochloride), Bupivacaine hydrochloride 2.5 mg/mL injection, solution, listed with the FDA by Xellia Pharmaceuticals USA LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- BUPIVACAINE HCl (Bupivacaine hydrochloride).
- What is the active ingredient?
- Bupivacaine hydrochloride.
- Who is the labeler?
- Xellia Pharmaceuticals USA LLC, NDC labeler code 70594. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for BUPIVACAINE HCl?
- 8 other product NDCs are listed under this name. See all BUPIVACAINE HCl NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other BUPIVACAINE HCl products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Bupivacaine HClbupivacaine hydrochloride | Bupivacaine hydrochloride 2.5 mg/mL | Injection, SolutionPerineural | Xellia Pharmaceuticals USA LLC | 70594-116 | 70594-0116-01 |
| Bupivacaine HClbupivacaine hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionPerineural | Xellia Pharmaceuticals USA LLC | 70594-119 | 70594-0119-01 |
| Bupivacaine HClbupivacaine hydrochloride | Bupivacaine hydrochloride 2.5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | Xellia Pharmaceuticals USA LLC | 70594-114 | 70594-0114-02 |
| Bupivacaine HClbupivacaine hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | Xellia Pharmaceuticals USA LLC | 70594-117 | 70594-0117-02 |
| Bupivacaine HClbupivacaine hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | Xellia Pharmaceuticals USA LLC | 70594-118 | 70594-0118-01 |
| Bupivacaine HClbupivacaine hydrochloride | Bupivacaine hydrochloride 7.5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | Xellia Pharmaceuticals USA LLC | 70594-120 | 70594-0120-02 |
| BUPIVACAINE HCl | Bupivacaine hydrochloride 2.5 mg/mL | Injection, SolutionInfiltration, Perineural | HF Acquisition Co LLC, DBA HealthFirst | 51662-1592 | 51662-1592-03 |
| BUPIVACAINE HCl | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionPerineural | HF Acquisition Co LLC, DBA HealthFirst | 51662-1588 | 51662-1588-03 |
Other NDCs under ANDA 091487
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Bupivacaine HClbupivacaine hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | Xellia Pharmaceuticals USA LLC | 70594-117 |
| Bupivacaine HClbupivacaine hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | Xellia Pharmaceuticals USA LLC | 70594-118 |
| Bupivacaine HClbupivacaine hydrochloride | Bupivacaine hydrochloride 7.5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | Xellia Pharmaceuticals USA LLC | 70594-120 |
| Bupivacine HClbupivacaine hydrochloride | Bupivacaine hydrochloride 7.5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | Xellia Pharmaceuticals USA LLC | 70594-121 |
| Bupivacaine HClbupivacaine hydrochloride | Bupivacaine hydrochloride 2.5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | Xellia Pharmaceuticals USA LLC | 70594-114 |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 2.5 mg/mL | Injection, SolutionEpidural, Infiltration | ONESOURCE SPECIALTY PHARMA LIMITED | 83270-162 |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural | ONESOURCE SPECIALTY PHARMA LIMITED | 83270-163 |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 7.5 mg/mL | Injection, SolutionEpidural, Retrobulbar | ONESOURCE SPECIALTY PHARMA LIMITED | 83270-164 |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 2.5 mg/mL | Injection, SolutionEpidural, Infiltration | ONESOURCE SPECIALTY PHARMA LIMITED | 83270-165 |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural | ONESOURCE SPECIALTY PHARMA LIMITED | 83270-166 |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 7.5 mg/mL | Injection, SolutionEpidural, Retrobulbar | ONESOURCE SPECIALTY PHARMA LIMITED | 83270-167 |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 2.5 mg/mL | Injection, SolutionEpidural, Infiltration | Fosun Pharma USA Inc. | 72266-263 |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural | Fosun Pharma USA Inc. | 72266-264 |